Yenyun Wang

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Beverly A. Teicher, Terence S. Herman, Sylvia A. Holden et al. · Science · 1990 · 316 citations

Vivo Passage, Medicine, Pharmacology +13

Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.

Yenyun Wang, Beverly A. Teicher, Thomas C. Shea et al. · PubMed · 1989 · 87 citations

Chemoprevention Strategy, Glutathione-s-transferase-pi Levels, Metronomic Chemotherapy +17

Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy

Purvish M. Parikh, Ashok K. Vaid, Suresh H. Advani et al. · Journal of Clinical Oncology · 2011 · 75 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer

Raghunadharao Digumarti, Yenyun Wang, G. Raman et al. · Journal of Thoracic Oncology · 2011 · 67 citations · Full text

Oncology, Medicine, Phase Ii Study +7